In Vivo Confocal Microscopy Tumor Atlas Study
Status unconfirmed · Phase 1
Conditions studied: Brain Neoplasms
In brief
This study aims to create an atlas based on the preliminary experience of the first feasibility study in neurosurgery. Hypothesis: That a confocal endomicroscope can be used during neurosurgery to provide in vivo histology that enables documentation of neurological pathology across a range of tumor ypes and grades, suitable for comparison with traditional histopathology from site-matched biopsies.
Key facts
- Study ID
- NCT01012154
- Run by
- Carl Zeiss Surgical GmbH
- People needed
- 150
- Starts
- 2009-11-01
- Expected to finish
- 2010-12-01
- Last updated by the study team
- 2009-11-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients with neurological pathology requiring surgery in which tumour resection might be evaluated by using biopsy
You may not qualify if…
- History of allergy to fluorescein
- Patients on beta-blockers or ACE inhibitors
- Pregnant women
- Inability to give informed consent
Where it is running
- Barrow Neurological Institute, St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.